Log in

Croda International Plc (LON:CRDA) Receives Consensus Rating of "Hold" from Brokerages

Wednesday, September 16, 2020 | MarketBeat

Croda International Plc (LON:CRDA) has earned a consensus rating of "Hold" from the sixteen analysts that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and three have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is GBX 4,932.50 ($64.45).

A number of equities analysts have recently commented on the company. JPMorgan Chase & Co. raised their price target on Croda International from GBX 4,025 ($52.59) to GBX 4,250 ($55.53) and gave the stock a "neutral" rating in a report on Tuesday, July 7th. Peel Hunt lowered Croda International to a "hold" rating and raised their price target for the stock from GBX 4,200 ($54.88) to GBX 4,650 ($60.76) in a report on Thursday, June 11th. Jefferies Financial Group raised their price target on Croda International from GBX 5,160 ($67.42) to GBX 5,700 ($74.48) and gave the stock a "hold" rating in a report on Monday, July 27th. Credit Suisse Group raised their price target on Croda International from GBX 3,900 ($50.96) to GBX 4,100 ($53.57) and gave the stock an "underperform" rating in a report on Thursday, May 28th. Finally, Societe Generale lifted their price objective on Croda International from GBX 5,000 ($65.33) to GBX 6,000 ($78.40) and gave the company a "hold" rating in a research note on Wednesday, July 29th.

Shares of LON CRDA opened at GBX 6,200 ($81.01) on Wednesday. The stock has a fifty day simple moving average of GBX 5,912.12 and a two-hundred day simple moving average of GBX 5,137.02. Croda International has a 1-year low of GBX 3,814 ($49.84) and a 1-year high of GBX 6,104 ($79.76). The firm has a market cap of $7.99 billion and a price-to-earnings ratio of 38.99. The company has a current ratio of 2.28, a quick ratio of 1.13 and a debt-to-equity ratio of 64.92.

The company also recently declared a dividend, which will be paid on Thursday, October 1st. Shareholders of record on Thursday, August 20th will be given a dividend of GBX 39.50 ($0.52) per share. The ex-dividend date of this dividend is Thursday, August 20th. This represents a yield of 0.71%. Croda International's payout ratio is 49.69%.

Croda International Company Profile

Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries.

Featured Article: How is a buy-side analyst different from a sell-side analyst?

Analyst Recommendations for Croda International (LON:CRDA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

10 Stocks to Buy On Fears of a Second Coronavirus Wave

Ever since the U.S. economy began to re-open (and honestly before that), there was concern over the impending “second wave” of the novel coronavirus. And although the second wave of the virus was not expected to hit until the fall, the concerns have been escalating as case numbers rise in multiple states.

And despite the Trump administration’s vehement statements that the economy would not shut down, we learned on February 25 that Texas was now pausing, and in some cases rolling back, its reopening measures in an effort to stem the spread of the virus.

And this is happening as the Centers for Disease Control (CDC) is now saying that it’s possible that 20 million Americans may have the coronavirus based on a sample of blood tests that are showing who has the antibodies in their system.

For its part, the stock market reacted sharply to the move. It was a move that undoubtedly frustrated many weary investors. In fact, you might be among those that have had just about enough of the Covid-19 market. I understand, I’m there too.

But, institutional investors are forward-looking. And right now, they don’t like what they. So stocks are having another broad selloff. However, in the midst of any selloff, there is money to be made. And the good news for investors is that many of the same stocks that were good buys in March, are still the stocks to buy right now. And while some of these stocks fit the classic definition of defensive stocks, you’ll find a few genuine growth stocks included on this list as well.

View the "10 Stocks to Buy On Fears of a Second Coronavirus Wave".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.